SCHEMBL5677947

SCHEMBL5677947

c1ccc(COCCOc2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.62
CYP1A2 P05177 1/20 0.62
PTGS1 P23219 1/20 0.62
SLC6A2 P23975 1/20 0.62
CYP2C19 P33261 1/20 0.62
PTGS2 P35354 1/20 0.62
SLC6A3 Q01959 1/20 0.62
HIF1A Q16665 1/20 0.62
HDAC6 Q9UBN7 1/20 0.62
MAOB P27338 3/20 0.60
RAB9A P51151 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
GAA P10253 1/20 0.60
MAPT P10636 1/20 0.60
MAOA P21397 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
FOXM1 Q08050 1/20 0.57
BCHE P06276 1/20 0.56
NPC1 O15118 1/20 0.56
TP53 P04637 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6852321 0.94 LMNA (0.64) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL16594362 0.94 TSHR (0.56) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL903883 0.92 TSHR (0.58) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL9808056 0.92 LMNA (0.72) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL8675401 0.90 LMNA (0.60) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL3120643 0.89 TSHR (0.50) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL9478520 0.88 KCNA3 (0.56) MAOBBCHELTA4HCHRNA7TSHR
SCHEMBL10795544 0.87 FOXM1 (0.57) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL10713484 0.87 TSHR (0.54) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL4756260 0.87 MAOB (0.70) LMNACYP1A2PTGS1SLC6A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165325-B1 THERMALLY-RESPONSIVE RECORD MATERIAL APPLETON PAPER INC (US) 2006-02-08 EP disclosed
EP-1159242-A4 MODIFIER COMPOUNDS APPLETON PAPER INC (US) 2004-11-24 EP disclosed
EP-1183224-B1 PROCESS FOR PREPARING ALKOXY OR ARYLMETHOXY AROXYETHANES APPLETON PAPER INC (US) 2004-08-04 EP disclosed
EP-1165325-A4 THERMALLY-RESPONSIVE RECORD MATERIAL APPLETON PAPER INC (US) 2004-03-24 EP disclosed
US-6566301-B2 Heat sensitive elements APPLETON PAPERS INC. 2003-05-20 US disclosed
EP-1183224-A4 PROCESS FOR PREPARING ALKOXY OR ARYLMETHOXY AROXYETHANES APPLETON PAPER INC (US) 2003-02-26 EP disclosed
US-6429341-B2 MODIFIERS OF HEAT SENSITIVE RECORDING ELEMENTS COMPRISING AROMATIC ETHER DERIVATIVES E.G., 2-(BENZYLOXY)ETHYL 4-(BENZYL OXY)PHENYL ETHER; MORE INTENSE IMAGE AT LOW TEMPERATURES; HIGH SPEED RESPONSE CHROMOGENS AND ACIDIC DEVELOPERS APPLETON PAPERS INC. 2002-08-06 US disclosed
EP-1183224-A1 PROCESS FOR PREPARING ALKOXY OR ARYLMETHOXY AROXYETHANES Appleton Papers Inc. (GB) 2002-03-06 EP disclosed
US-20020006868-A1 Thermally-responsive record material APPVION OPERATIONS, INC. 2002-01-17 US disclosed
US-20020007091-A1 Modifier compounds APPLETON PAPERS INC. 2002-01-17 US disclosed
US-20020002311-A1 Process for preparing alkoxy or arylmethoxy aroxyethanes APPLETON PAPERS INC. 2002-01-03 US disclosed
EP-1165325-A1 THERMALLY-RESPONSIVE RECORD MATERIAL Appleton Papers Inc. (GB) 2002-01-02 EP disclosed
EP-1159242-A1 MODIFIER COMPOUNDS Appleton Papers Inc. (GB) 2001-12-05 EP disclosed
US-6323376-B1 REACTING SUBSTITUTED OR UNSUBSTITUTED PHENOLS OR NAPHTHOLS WITH ETHYLENE CARBONATE IN PRESENCE OF CATALYST SELECTED FROM METAL HALIDE, QUARTERNARY AMMONIUM HALIDE AND QUARTERNARY PHOSPHONIUM HALIDE; REACTING INTERMEDIATE ARALKYL HALIDE APPLETON PAPERS INC. 2001-11-27 US disclosed
WO-2001060775-A1 PROCESS FOR PREPARING ALKOXY OR ARYLMETHOXY AROXYETHANES APPLETON PAPERS INC. (US) 2001-08-23 WO disclosed
WO-2001049507-A1 THERMALLY-RESPONSIVE RECORD MATERIAL APPLETON PAPERS INC. (US) 2001-07-12 WO disclosed
WO-2001049641-A1 MODIFIER COMPOUNDS APPLETON PAPERS INC. (US) 2001-07-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020002311-A1 Process for preparing alkoxy or arylmethoxy aroxyethanes ARSA, PHYKPL, CCNY LMNA 3418/4885CYP1A2 295/4885PTGS1 3268/4885
US-20020007091-A1 Modifier compounds EBPL, H1-0, ADCY7 LMNA 2643/4885CYP1A2 369/4885PTGS1 2534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.